Clinical Trial Update: Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer. [Phase 2]

View source ↗

Summary

Phase II trial evaluating hypofractionated radiochemotherapy with gemcitabine and oxaliplatin for unresectable, nonmetastatic locally advanced pancreatic cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Unresectable Pancreatic Cancer, Nonmetastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED